End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.6 INR | -0.86% |
|
-1.42% | -23.45% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 2,776 | 2,230 | 2,692 | 2,957 |
EBITDA 1 | 94.54 | 80.15 | 107.9 | 180.3 |
EBIT 1 | 79.25 | 68.1 | 96.71 | 170.8 |
Operating Margin | 2.86% | 3.05% | 3.59% | 5.78% |
Earnings before Tax (EBT) 1 | 23.93 | 12.71 | 24.28 | 98.68 |
Net income 1 | 16 | 6.911 | 16.46 | 67.25 |
Net margin | 0.58% | 0.31% | 0.61% | 2.27% |
EPS 2 | 1.172 | 0.5058 | 1.206 | 4.926 |
Free Cash Flow | - | 16.85 | -93.2 | -3.414 |
FCF margin | - | 0.76% | -3.46% | -0.12% |
FCF Conversion (EBITDA) | - | 21.02% | - | - |
FCF Conversion (Net income) | - | 243.79% | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 21/03/23 | 21/03/23 | 21/03/23 | 02/09/23 |
Balance Sheet Analysis
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 265 | 352 | 437 | 455 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | 2.807 x | 4.389 x | 4.045 x | 2.521 x |
Free Cash Flow | - | 16.8 | -93.2 | -3.41 |
ROE (net income / shareholders' equity) | - | 6.08% | 13.1% | 40.2% |
ROA (Net income/ Total Assets) | - | 7.03% | 8.17% | 12.1% |
Assets 1 | - | 98.36 | 201.6 | 557.7 |
Book Value Per Share 2 | 8.070 | 8.570 | 9.790 | 14.70 |
Cash Flow per Share 2 | 2.020 | 2.490 | 5.910 | 7.680 |
Capex 1 | 10.3 | 11.6 | 4.57 | 4.45 |
Capex / Sales | 0.37% | 0.52% | 0.17% | 0.15% |
Announcement Date | 21/03/23 | 21/03/23 | 21/03/23 | 02/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-23.45% | 77.56L | |
+26.84% | 44TCr | |
+38.61% | 29TCr | |
+18.04% | 15TCr | |
+11.38% | 9.63TCr | |
+23.25% | 8.74TCr | |
+66.99% | 6.25TCr | |
+10.00% | 4.45TCr | |
+14.04% | 3.41TCr | |
-15.16% | 3.03TCr |
- Stock Market
- Equities
- CELLPOINT Stock
- Financials Cell Point (India) Limited